Finding the Right Drug at the Right Dose the First Time: Has the Era of Personalized Formularies Finally Arrived?

drug dose, dose, pharmacogenomics, Personalized medicine

Many Americans take medications that are ineffective or cause adverse reactions due to genetic differences in drug metabolism. Pharmacogenomics, the study of how genes affect drug response, can help tailor medications to individual genetic profiles, reducing trial and error in prescriptions. A s…

Sep 27^th • 1 min read

First person profile: William Sellers, MD

William Sellers, Dana Farber Cancer Institute, Harvard, melanoma

Dr. Sellers is a prominent figure in cancer research, associated with the Broad Institute of MIT and Harvard, Dana-Farber Cancer Institute, and Harvard Medical School. He has contributed significantly to cancer genomics, particularly in identifying EGFR mutations in lung cancer a…

Nov 6^th • 2 mins read

Precision medicine for pediatric cancers lags behind that for adult cancers: Citing hurdles in clinical trial recruitment and drug development, researchers are exploring ways to close gaps

Precision Medicine, pediatrics, clinical trials

Pediatric precision oncology faces challenges due to the rarity of pediatric cancers, which limits research and funding compared to adult cancers. Dr. Katherine Janeway highlights the need for more validated pre-clinical models and pharmaceutical interest in pediatric cancers. The RACE Act, effe…

Jan 9^th • 2 mins read